Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginTimes Interest Earned

Cellectis (CLLS) Invested Capital (2016 - 2025)

Cellectis (CLLS) has 8 years of Invested Capital data on record, last reported at $123.1 million in Q4 2022.

  • For Q4 2022, Invested Capital fell 65.91% year-over-year to $123.1 million; the TTM value through Dec 2022 reached $123.1 million, down 65.91%, while the annual FY2022 figure was $123.1 million, 65.91% down from the prior year.
  • Invested Capital reached $123.1 million in Q4 2022 per CLLS's latest filing, down from $361.0 million in the prior quarter.
  • Across five years, Invested Capital topped out at $438.8 million in Q4 2020 and bottomed at $123.1 million in Q4 2022.
  • Average Invested Capital over 4 years is $333.1 million, with a median of $385.3 million recorded in 2018.
  • Peak YoY movement for Invested Capital: skyrocketed 44.23% in 2018, then crashed 65.91% in 2022.
  • A 4-year view of Invested Capital shows it stood at $409.6 million in 2018, then rose by 7.13% to $438.8 million in 2020, then dropped by 17.73% to $361.0 million in 2021, then plummeted by 65.91% to $123.1 million in 2022.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $123.1 million in Q4 2022, $361.0 million in Q4 2021, and $438.8 million in Q4 2020.